125 related articles for article (PubMed ID: 36308567)
21. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
22. DHA2, a synthesized derivative of bisbibenzyl, exerts antitumor activity against ovarian cancer through inhibition of XIAP and Akt/mTOR pathway.
Pang Y; Si M; Sun B; Niu L; Xu X; Lu T; Yuan H; Lou H
Food Chem Toxicol; 2014 Jul; 69():163-74. PubMed ID: 24751974
[TBL] [Abstract][Full Text] [Related]
23. A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR-1 mediated mitochondrial dysfunction and apoptosis.
Ma L; Zhang H; Liu C; Liu M; Shangguan F; Liu Y; Yang S; Li H; An J; Song S; Cao Q; Qu G
Environ Toxicol; 2023 May; 38(5):1118-1132. PubMed ID: 36810933
[TBL] [Abstract][Full Text] [Related]
24. Lysine-Specific Demethylase 1 (LSD1) Inhibitor S2101 Induces Autophagy via the AKT/mTOR Pathway in SKOV3 Ovarian Cancer Cells.
Feng S; Jin Y; Cui M; Zheng J
Med Sci Monit; 2016 Dec; 22():4742-4748. PubMed ID: 27914215
[TBL] [Abstract][Full Text] [Related]
25. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
[TBL] [Abstract][Full Text] [Related]
26. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway.
Kattan SW; Nafie MS; Elmgeed GA; Alelwani W; Badar M; Tantawy MA
J Steroid Biochem Mol Biol; 2020 Apr; 198():105604. PubMed ID: 31982513
[TBL] [Abstract][Full Text] [Related]
27. Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway.
Xing F; Sun C; Luo N; He Y; Chen M; Ding S; Liu C; Feng L; Cheng Z
Med Sci Monit; 2019 Aug; 25():6007-6014. PubMed ID: 31402794
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85.
Wu D; Lu P; Mi X; Miao J
Arch Gynecol Obstet; 2018 Mar; 297(3):699-707. PubMed ID: 29327155
[TBL] [Abstract][Full Text] [Related]
29. The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer.
Dobbin ZC; Landen CN
Int J Mol Sci; 2013 Apr; 14(4):8213-27. PubMed ID: 23591839
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
Liu H; Li X; Duan Y; Xie JB; Piao XL
J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
[TBL] [Abstract][Full Text] [Related]
31. HULC functions as an oncogene in ovarian carcinoma cells by negatively modulating miR-125a-3p.
Chu P; Xu L; Su H
J Physiol Biochem; 2019 Jun; 75(2):163-171. PubMed ID: 30863948
[TBL] [Abstract][Full Text] [Related]
32. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
[TBL] [Abstract][Full Text] [Related]
33. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
34. JTC-801 inhibits the proliferation and metastasis of ovarian cancer cell SKOV3 through inhibition of the PI3K - AKT signaling pathway.
Li JX; Bi YP; Wang J; Yang X; Tian YF; Sun ZF
Pharmazie; 2018 May; 73(5):283-287. PubMed ID: 29724295
[TBL] [Abstract][Full Text] [Related]
35. Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma.
Santiskulvong C; Konecny GE; Fekete M; Chen KY; Karam A; Mulholland D; Eng C; Wu H; Song M; Dorigo O
Clin Cancer Res; 2011 Apr; 17(8):2373-84. PubMed ID: 21372221
[TBL] [Abstract][Full Text] [Related]
36. Preclinical testing of PI3K/AKT/mTOR signaling inhibitors in a mouse model of ovarian endometrioid adenocarcinoma.
Wu R; Hu TC; Rehemtulla A; Fearon ER; Cho KR
Clin Cancer Res; 2011 Dec; 17(23):7359-72. PubMed ID: 21903772
[TBL] [Abstract][Full Text] [Related]
37. CADM1 inhibits ovarian cancer cell proliferation and migration by potentially regulating the PI3K/Akt/mTOR pathway.
Si X; Xu F; Xu F; Wei M; Ge Y; Chenge S
Biomed Pharmacother; 2020 Mar; 123():109717. PubMed ID: 31865146
[TBL] [Abstract][Full Text] [Related]
38. Disodium pentaborate decahydrate (DPD) induced apoptosis by decreasing hTERT enzyme activity and disrupting F-actin organization of prostate cancer cells.
Korkmaz M; Avcı CB; Gunduz C; Aygunes D; Erbaykent-Tepedelen B
Tumour Biol; 2014 Feb; 35(2):1531-8. PubMed ID: 24122279
[TBL] [Abstract][Full Text] [Related]
39. Antidiabetic drug metformin mitigates ovarian cancer SKOV3 cell growth by triggering G2/M cell cycle arrest and inhibition of m-TOR/PI3K/Akt signaling pathway.
Fu YL; Zhang QH; Wang XW; He H
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):1169-1175. PubMed ID: 28338172
[TBL] [Abstract][Full Text] [Related]
40. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
Zhang L; Liu XL; Yuan Z; Cui J; Zhang H
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
